Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Xbrane Biopharma AB
XBRANECurrent price
0.23 SEK
-0.0085 SEK (-3.62%)
Last closed
0.23 SEK
Company
www.xbrane.com
ISIN
SE0007789409
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
321 286 437 SEK
Yield for 12 month
-99.05 %
1Y
3Y
5Y
10Y
15Y
XBRANE
Xbrane Biopharma AB (publ), a biotechnology company, engages in the development, manufacture, and sale of biosimilars. The company offers Ximluci, a ranibizumab biosimilar used for the treatment of wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy, retinal vein occlusion, and visual impairment due to cordial neovascularization in adults. Its pre-clinical phase products include BIIB801, a certolizumab pegol biosimilar candidate, indicated for the treatment of rheumatoid arthritis, axial spondylarthrosis, psoriatic arthritis, and psoriasis, Crohn's disease, and axial spondylitis; Xdivane, a nivolumab biosimilar candidate, indicated for melanoma, lung cancer, kidney cell cancer, head and neck cancer, and bladder and urinary tract cancer; and Xdarzane, a daratumumab biosimilar candidate, indicated for multiple melanoma. The company was incorporated in 2008 and is headquartered in Solna, Sweden. Address: Retzius vAeg 8, Solna, Sweden, 171 65
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
14.95 SEKP/E ratio
–Dividend Yield
–Current Year
+237 668 348 SEK
Last Year
+57 362 009 SEK
Current Quarter
+66 514 160 SEK
Last Quarter
+51 768 971 SEK
Current Year
+13 893 004 SEK
Last Year
+40 859 656 SEK
Current Quarter
+35 926 667 SEK
Last Quarter
+65 094 501 SEK
Key Figures XBRANE
1 year
3 years
5 years
10 years
EBITDA
-253 241 851 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-19.2 %
PEG Ratio
–
Return On Equity TTM
-103.07 %
Wall Street Target Price
14.95 SEK
Revenue TTM
198 919 282 SEK
Book Value
0.17 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
13.5 %
Dividend Yield
–
Gross Profit TTM
57 362 008 SEK
Earnings per share
-1.19 SEK
Diluted Eps TTM
-1.19 SEK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-185.46 %
Dividend Analytics XBRANE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History XBRANE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation XBRANE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
5.2743
Enterprise Value Revenue
2.1819
Price Sales TTM
1.6152
Enterprise Value EBITDA
-2.4116
Price Book MRQ
1.0597
Financials XBRANE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators XBRANE
For 52 weeks
0.13 SEK
26.63 SEK
50 Day MA
0.17 SEK
Shares Short Prior Month
–
200 Day MA
0.6 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart